
Celetoin 50mg/2ml Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Phenytoin (50mg/2ml)
Overview Celetoin 50mg/2ml Injection
Epileptic seizures are treated and prevented with the injectable formulation of Celetrox, 50mg/2ml. This medication works by reducing excessive, irregular neuronal firing in the brain. Parenteral administration is necessary when oral ingestion is impossible, such as during hospitalization. Celetrox 50mg/2ml Injection may be used independently or as part of a combination therapy, always following the physician's prescribed dosage and duration. Dosage may be increased gradually to optimize seizure control. While therapeutic effects may not be immediately apparent (requiring several weeks), consistent use is crucial for efficacy. Discontinuing the medication prematurely, without medical supervision, risks increased seizure frequency and potential exacerbation of bipolar disorder. Common adverse reactions include dermatological rashes, cephalgia, nausea/vomiting, insomnia, vertigo, somnolence. While most side effects are transient, persistent or bothersome symptoms require medical attention; strategies for mitigation may be available. Prior to treatment, disclose any pre-existing renal or hepatic impairment, meningitis, depression, or suicidal ideation to your physician. Inform your healthcare provider of all concurrent medications, including hormonal contraceptives, as potential interactions exist. Use during pregnancy or lactation requires careful assessment and potential dosage adjustments, based on clinical need. Operation of machinery (driving, cycling) should be avoided if drowsiness or dizziness occurs. Regular blood monitoring may be necessary to assess therapeutic response.
Uses of Celetoin 50mg/2ml Injection
Managing and mitigating epileptic seizures.
Major Benefits of Celetoin 50mg/2ml Injection:
This medication will be administered by your physician or their qualified staff; self-medication is strictly prohibited.
Common Side effects of Celetoin 50mg/2ml Injection:
- Rash
- Headache
- Dizziness
- Vomiting
- Nausea
- Slurred speech
- Vertigo
- Confusion
- Nervousness
- Constipation
- Tremors
- Altered walking
How to use Celetoin 50mg/2ml Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Celetoin 50mg/2ml Injection works:
Epileptic seizures are managed by the anticonvulsant injection, Celetoin 50mg/2ml. This medication reduces excessive, irregular neuronal firing in the brain, thereby controlling fits.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Celetoin 50mg/2ml Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Celetoin 50mg/2ml Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary when the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administering Celetoin 50mg/2ml Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant. However, physician consultation is recommended.
DrivingUNSAFE
Administering Celetoin 50mg/2ml Injection might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with impaired kidney function, administering Celetoin 50mg/2ml Injection requires careful consideration. Dosage modification of Celetoin 50mg/2ml Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Celetoin 50mg/2ml Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Celetoin 50mg/2ml Injection :
Omit a dose of Celetoin 50mg/2ml Injection? Seek medical advice.
Facts to Know About Celetoin 50mg/2ml Injection
| Label | Value |
|---|---|
| Chemical Type | Hydantoin-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
